CLINICAL_TRIALS
trial_result
· 2021-06-18
Clinical Trial Update: Cisplatin vs Paclitaxel for Triple Negative Breast Cancer [Phase 2]
Summary
A Phase 2 trial comparing cisplatin versus paclitaxel for triple-negative breast cancer has completed, with results posted in 2021.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Dana-Farber Cancer Institute | Conditions: Triple Negative Breast Cancer | Phase 2 | Status: COMPLETED | Results posted: 2021-06-18